You are here: Introduction > Further information
 
        PreviousNext
 
Fitergol:  Further information
 
 
Fitergol
Further information
Nicergoline is an alpha-blocking cerebral vasodilator.
The activity of nicergoline is primarily due to blockade of α 1 and α 2 adrenoceptors.
Nicergoline also blocks serotonin and dopamine receptors.
Nicergoline demonstrates a wide safety margin.
Administration of up to 90 times the normal recommended dose in dogs for 6 months has shown no adverse effect.
           
 
        PreviousNext
  Date updated: 29 November 2005